nivolumab in combination with azacitidine in patients with relapsed acute myeloid leukemia (aml)
Published 7 years ago • 168 plays • Length 1:42
Download video MP4
Download video MP3
Similar videos
-
2:42
aaron trial: relatlimab, nivolumab and 5-azacitidine combination in r/r aml
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
8:16
nivolumab for oesophageal cancer following chemoradiation therapy
-
21:24
cell surface markers: cd3, cd4, cd8, cd19, cd28, cd16, cd56
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
1:40
pivekimab sunirine in combination with venetoclax and azacitidine for cd123-positive aml
-
4:20
new nivolumab combination therapies for aml
-
2:11
clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (aml)
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:40
azacitidine/hdac inhibitor combination for high risk aml: a promising pilot study
-
2:14
insights into the enhance-3 study: azacitidine plus venetoclax with or without magrolimab in aml
-
2:27
emavusertib in combination with azacitidine and venetoclax in patients with aml
-
4:52
phase ib/ii study of nivolumab with azacytidine in patients with relapsed aml
-
1:12
phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml
-
5:09
phase ib/ii study of nivolumab in combination with azacytidine in patients with relapsed aml
Clip.africa.com - Privacy-policy